Actively Recruiting
Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
Led by Fundacion Miguel Servet · Updated on 2020-09-21
1000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
CONDITIONS
Official Title
Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
- Patients being operated by the HPB Surgical Unit from January 2019 onwards who provide informed consent (prospective)
You will not qualify if you...
- Patients not eligible for surgery
- Patients not interested in taking part in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain, 31008
Actively Recruiting
Research Team
F
Francisco Javier Herrera Cabezón, MD
CONTACT
P
Pablo Sánchez Acedo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here